BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37933333)

  • 21. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
    He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M
    Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parenchymal Sparing Laparoscopic Segmentectomy III and IV with Indocyanine Green Fluorescence Negative Stain Method Using Glisson Pedicle Approach.
    Wan H; Xie K; Wu H
    J Gastrointest Surg; 2023 Jan; 27(1):203-204. PubMed ID: 36357739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic Arterial Infusion Chemotherapy as a Timing Strategy for Conversion Surgery to Treat Hepatocellular Carcinoma: A Single-Center Real-World Study.
    Wang J; Zheng Z; Wu T; Li W; Wang J; Pan Y; Peng W; Hu D; Hou J; Xu L; Zhang Y; Chen M; Zhang R; Zhou Z
    J Hepatocell Carcinoma; 2022; 9():999-1010. PubMed ID: 36132426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison Between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate to Advanced Stage Hepatocellular Carcinoma.
    Pan Y; Mei J; Chen J; Zhang D; Wang J; Wang X; Yi M; Zhou Z; Zhang Y; Chen M; Guo R; Xu L
    Ann Surg Oncol; 2022 Mar; 29(3):2016-2029. PubMed ID: 34637058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergency open drainage of massive hemoperitoneum and early stage left hepatectomy for abdominal compartment syndrome due to hepatocellular carcinoma rupture: a case report.
    Kurimoto M; Yamanaka K; Hirata M; Umeda M; Yamashita T; Aoki H; Hanabata Y; Shinkura A; Tamura J
    Surg Case Rep; 2022 Jun; 8(1):122. PubMed ID: 35731449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A Case in Which Multiple Post-Operatively Recurring Hepatocellular Carcinomas Showed a Positive Response to Sorafenib-Hepatic Arterial Infusion Chemotherapy (HAIC)Sequential Therapy].
    Iwata N; Ishii Y; Yoshida Y; Kikuchi T; Mita H; Adachi Y; Adachi Y; Minami T; Ikeda K; Makiguchi Y; Hata F; Kato Y; Endo T
    Gan To Kagaku Ryoho; 2021 Feb; 48(2):215-218. PubMed ID: 33597362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant hepatic arterial infusion chemotherapy after radical hepatectomy for hepatocellular carcinoma--results of long-term follow-up.
    Asahara T; Itamoto T; Katayama K; Ono E; Dohi K; Nakanishi T; Kitamoto M; Azuma K; Ito K
    Hepatogastroenterology; 1999; 46(26):1042-8. PubMed ID: 10370664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial.
    Kondo M; Morimoto M; Kobayashi S; Ohkawa S; Hidaka H; Nakazawa T; Aikata H; Hatanaka T; Takizawa D; Matsunaga K; Okuse C; Suzuki M; Taguri M; Ishibashi T; Numata K; Maeda S; Tanaka K
    BMC Cancer; 2019 Oct; 19(1):954. PubMed ID: 31615466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Estimation of hepatic resection volume in hepatocellular carcinoma by ICG(R15) and its relation with postoperative liver failure].
    Lao XM; Zhang YQ; Lin XJ; Guo RP; Chen MS; Yuan YF; Li JQ; Li GH
    Ai Zheng; 2005 Mar; 24(3):337-40. PubMed ID: 15757537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical treatment after hepatic arterial infusion chemotherapy for hepatocellular carcinoma extending into the right atrium.
    Kurahashi S; Sano T; Natsume S; Senda Y; Yamaura H; Inaba Y; Shimizu Y
    Surg Case Rep; 2015; 1(1):47. PubMed ID: 26366344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic Resection Followed by Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma with Intrahepatic Dissemination.
    Kuramoto K; Beppu T; Nitta H; Imai K; Masuda T; Miyata T; Koga Y; Kitano Y; Kaida T; Nakagawa S; Okabe H; Hayashi H; Hashimoto D; Yamashita YI; Chikamoto A; Kikuchi K; Baba H
    Anticancer Res; 2018 Jan; 38(1):525-531. PubMed ID: 29277819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A Case of Pathologically Complete Response in Ruptured Hepatocellular Carcinoma Treated with Transcatheter Arterial Embolization].
    Yoshikawa T; Sakamoto H; Asakura R; Ogawa H; Hirano S
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2147-2149. PubMed ID: 30692313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rare case of a spontaneously ruptured secondary hepatic malignant lymphoma.
    Oshita K; Itamoto T; Oshita A; Nakahara H; Nishisaka T
    Surg Case Rep; 2018 May; 4(1):44. PubMed ID: 29725882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases.
    Higuchi T; Kikuchi M; Okazaki M
    Cancer; 1994 May; 73(9):2259-67. PubMed ID: 7513245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic resection for hepatocellular carcinoma existing with liver cirrhosis.
    Ezaki T; Yamamoto K; Yamaguchi H; Sasaki Y; Ishida T; Mori M; Aimitsu S
    Hepatogastroenterology; 2002; 49(47):1363-8. PubMed ID: 12239943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unusual Techniques for Preserving Surgical and Oncologic Safety in Hepatectomy of Advanced Adrenal Malignancy with Vena Cava and Liver Invasion.
    Lee JM; Lee KW; Hong SK; Yoon KC; Cho JH; Yi NJ; Suh KS
    Ann Surg Oncol; 2018 Oct; 25(11):3324-3325. PubMed ID: 30019302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of literature.
    Chu JH; Huang LY; Wang YR; Li J; Han SL; Xi H; Gao WX; Cui YY; Qian MP
    World J Gastrointest Oncol; 2024 Apr; 16(4):1647-1659. PubMed ID: 38660668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case report of postoperative recurrent hepatocellular carcinoma effectively treated with HCFU administration combined with TAE].
    Imai Y; Ito J; Tanzawa Y; Toda N; Okamoto M; Kobayashi K; Taniguchi M; Uta Y; Tagawa K; Unuma T
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):901-4. PubMed ID: 1318699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combined Modality Therapy for Giant Hepatocellular Carcinoma and Multiple Lung Metastases-A Case Study].
    Hasegawa H; Kawakubo E; Kitagawa D; Kishihara F; Funahashi S; Kitamura M
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):2251-2253. PubMed ID: 33468924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical resection after down-staging of locally advanced hepatocellular carcinoma by localized concurrent chemoradiotherapy.
    Lee HS; Choi GH; Choi JS; Kim KS; Han KH; Seong J; Ahn SH; Kim DY; Park JY; Kim SU; Kim BK
    Ann Surg Oncol; 2014 Oct; 21(11):3646-53. PubMed ID: 24916746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.